Obesity Abstracts

The last 18-months has witnessed the collision of the epidemics of diabetes, obesity and COVID-19. The consistent finding of adverse outcomes, from COVID-19, in individuals with diabetes and/or obesity – even with hyperglycaemia in the non-diabetic range – has focused attention on the metabolic dysfunction that may arise with acute illness and the potential benefit to be gained from glycaemic regulation. Significantly worse outcomes in people with microvascular compl...

Background: Ethnicity and obesity have been recently established as risk factors for adverse coronavirus disease 19 (COVID-19) outcomes. The prevalence of obesity differs across ethnic groups. Thus, previously reported ethnic differences in COVID-19 outcomes may be due to underlying variations in BMI.Aims: To investigate the association between ethnicity and in-hospital mortality in COVID-19, and the effect of BMI. The secondary aim was to investigate th...